ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645991 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645991; 2) Community: the network communities that were significantly associated with the response to NSC 645991; 3) Molecule: the relationships between components within communities and NSC 645991; 4) MDR: the compounds that were significantly associated with the NSC 645991.

NSC Compound Enrichment Correlation
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0174989034030623 0.29954637
NSC 759274 ARSENIC TRIOXIDE 0.0174989034030623 0.4498979
NSC 118218 2-Fluoro Ara A 0.0201565205286438 0.15892885
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0201565205286438 0.15483512
NSC 19441 FDA 0283 0.0201565205286438 0.087202288
NSC 309895 Null 0.0201565205286438 -0.1516541
NSC 343378 1H-Indene-1,3(2H)-dione, 2-[[(2-methylphenyl)imino]phenylmethyl]- 0.0201565205286438 0.2592406
NSC 348402 Null 0.0201565205286438 0.39813739
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0201565205286438 -0.024124519
NSC 526333 2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime 0.0201565205286438 0.44507342
Total:113  Current:51    [First] [Prev] [Next] [Last]